期刊文献+

利用启动子缺陷型打靶载体敲除牛胎儿成纤维细胞中的Prnp 被引量:2

Targeting Prnp in Bovine Fibroblasts by Promoter-trap Strategy
下载PDF
导出
摘要 利用启动子捕获对中靶细胞进行富集是提高体细胞基因打靶效率常用的策略之一。敲除动物的Prnp可使其具有抵抗Prion病感染的能力。采用启动子捕获策略,构建了牛Prnp启动子缺陷型打靶载体BoPrneo,线性化后,再通过电穿孔转染牛胎儿成纤维细胞BFF,用250μg/mL G418进行药物筛选,共得到99个药物抗性细胞克隆。对细胞克隆进行PCR、测序及Southern blotting鉴定,结果表明,其中的4个细胞克隆为中靶细胞,说明牛胎儿成纤维细胞中的Prnp一条等位基因被成功敲除。本研究为牛Prnp的敲除提供了一种简单、安全、有效的方法。 Promoter-trap strategy for enriching targeted colonies has been usually used to elevate the gene targeting efficiency in somatic cells. Knocking out Prnp in animals by gene targeting can render them resistant to Prion diseases. We constructed a bovine Prnp promoter-less targeting vector BoPrPneo, then transfected the linearized vector into the bovine fetal fibroblasts BFF through electroporation. After selecting in cell culture medium with 250 μg/mL G418, we obtained 99 drug-resistant cell colonies, 4 of them were positive for targeted events after PCR screening, and the targeted colonies were further confirmed by sequencing and Southern blotting. This suggests that one allele of Prnp has been successfully knocked out in bovine fetal fibroblasts. This research supplies a simple, safe and effective method to targeting bovine Prnp.
出处 《生物工程学报》 CAS CSCD 北大核心 2008年第11期1988-1992,共5页 Chinese Journal of Biotechnology
基金 上海市青年科技启明星计划项目(No.07QB14022) 国家博士后科学基金(No.20060400174)资助~~
关键词 基因打靶 启动子捕获策略 PRION病 牛胎儿成纤维细胞 PRNP gene targeting, promoter-trap strategy, Prion diseases, bovine fetal fibroblasts, Prnp
  • 相关文献

参考文献13

  • 1Thomson AJ, Marques MM, McWhir J. Gene targeting in livestock. Reprod Suppl, 2003, 61: 495-508.
  • 2Sorrell DA, Kolb AF. Targeted modification of mammalian genomes. Biotechnol Adv, 2005, 23(7-8): 431-469.
  • 3朱采红,俞国华,李蓓,陈建泉,成国祥.哺乳动物Prion病研究新进展[J].中国人兽共患病学报,2007,23(11):1156-1159. 被引量:3
  • 4Aguzzi A, Heikenwalder M. Pathogenesis of prion disease: current status and future outlook. Nat Rev Microbiol, 2006, 4(10): 765-775.
  • 5Bueler H, Fischer M, Lang Y, et al. Normal development and behaviour of mice lacking the neuronal cell-surface PrP protein. Nature, 1992, 356(6370): 577-582.
  • 6Mallucci GR, White MD, Farmer M, et al. Targeting cellular prion protein reverses early cognitive deficits and neurophysiological dysfunction in prion-infected mice. Neuron, 2007, 53(3): 325-335.
  • 7Kuroiwa Y, Kasinathan P, Matsushita H, et al. Sequential targeting of the genes encoding immunoglobulin-mu and prion protein in cattle. Nat Genet, 2004, 36(7): 775-780.
  • 8Hirata RK, Xu C, Dong R, et al. Efficient PRNP gene targeting in bovine fibroblasts by adeno-associated virus vectors. Cloning Stem Cells, 2004, 6(1): 31-36.
  • 9Yu G, Chen J, Yu H, et al, Functional disruption of the priori protein gene in cloned goats. J Gen Virol, 2006, 87(Pt4): 1019-1027.
  • 10Sedivy JM, Dutriaux A. Gene targeting and somatic cell genetics-a rebirth or a coming of age? Trends Genet, 1999, 15(3): 88-90.

二级参考文献36

  • 1俞国华,刘思国,成国祥.蛋白质:生物界中又一类信息的储存者和传递者——对prion生物学相关知识的重新解读[J].生物化学与生物物理进展,2005,32(8):698-706. 被引量:2
  • 2Chesebro B, Trifilo M, Race R, et al. Anchorless prion protein results in infectious amyloid disease without clinical scrapie[J]. Science, 2005, 308(5727) :1435-1439.
  • 3Harris A, True H L. New insights into prion structure and toxicity[J]. Neuron, 2006, 50(3): 353-357.
  • 4Polymenidou M, Stoeck K, Glatzel M, et al. Coexistence of multiple PrP^Sc types in individuals with Creutzfeldt-Jakob disease[J]. Lancet Neurol, 2005, 4(12): 805-814.
  • 5Saa P, Castilla J, Soto C. Presymptomatic detection of prions in blood[J]. Science, 2006, 313(5783): 92-94.
  • 6Klohn P C, Stoltze L, Flechsig E, et al. A quantitative, highly sensitive cell-based infectivity assay for mouse scrapie prions [J]. Proc Natl Acad Sci LISA, 2003,100(20): 11666-11671.
  • 7Caughey B, Baron G S. Prions and their partners in crime[J]. Nature, 2006, 433(7113): 803-810.
  • 8Weissmann C, Aguzzi A. Approaches to therapy of Priori Diseases[J]. Annu Rev Med, 2005, 56:321-344.
  • 9Caughey B, Caughey W S, Kocisko D A, et al. Prions and transmissible spongiform encephalopathy (TSE) chemotherapeutics: A common mechanism for anti-TSE compounds?[J]. Ace Chem Res, 2006, 39(9) :646-653.
  • 10Scoazec J Y, Krolak-Salmon P, Casez O, et al. Quinacrine-induced cytolytic hepatitis in sporadic Creutzfeldt-Jakob disease [J]. Ann Neurol, 2003, 53(4): 546-547.

共引文献2

同被引文献38

引证文献2

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部